NCT03160040

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting

Retrospective, Observational Evaluation of the Utilization, Outcomes, and Adverse Events Associated With Minocin IV for the Treatment of Infections Presumed or Confirmed to be Caused by Gram-negative Bacteria in a Real World Setting

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 71 (actual)
• Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is a retrospective, observational study to evaluate minocycline use in participants under real world conditions.

Detailed description

This study is a retrospective, observational study to evaluate minocycline use in participants under real world conditions.

Conditions

• Gram-Negative Bacterial Infections

Interventions

Type	Name	Description
DRUG	Minocycline IV	This study is an observational study. All participants were administered minocycline IV prior to enrollment in this study.

Timeline

• Start date: 2017-10-11
• Primary completion: 2018-05-01
• Completion: 2018-05-01
• First posted: 2017-05-19
• Last updated: 2023-08-28

Locations

6 sites across 1 country: United States

Regulatory

• FDA-regulated drug study